Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Expression of VEGF(121) in gastric carcinoma MGC803 cell line.

Literature DB >> 11819577

Expression of VEGF(121) in gastric carcinoma MGC803 cell line.

Jun-Tian Xue, Jian Wu, Lin Meng, Zhi-Wei Dong, Cheng-Chao Shou.

Abstract

Entities: Disease Gene

Year: 2000 PMID： 11819577 PMCID： PMC4723505 DOI： 10.3748/wjg.v6.i2.281

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

× No keyword cloud information.

6 in total

1. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

Authors: D T Connolly; D M Heuvelman; R Nelson; J V Olander; B L Eppley; J J Delfino; N R Siegel; R M Leimgruber; J Feder
Journal: J Clin Invest Date: 1989-11 Impact factor: 14.808

2. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.

Authors: K J Kim; B Li; J Winer; M Armanini; N Gillett; H S Phillips; N Ferrara
Journal: Nature Date: 1993-04-29 Impact factor: 49.962

3. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

Authors: L F Brown; B Berse; R W Jackman; K Tognazzi; E J Manseau; D R Senger; H F Dvorak
Journal: Cancer Res Date: 1993-10-01 Impact factor: 12.701

4. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

Authors: K H Plate; G Breier; H A Weich; W Risau
Journal: Nature Date: 1992-10-29 Impact factor: 49.962

5. Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121).

Authors: M Asano; A Yukita; T Matsumoto; K Matsuo; S Kondo; H Suzuki
Journal: Hybridoma Date: 1995-10

6. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.

Authors: S Wizigmann-Voos; G Breier; W Risau; K H Plate
Journal: Cancer Res Date: 1995-03-15 Impact factor: 12.701

6 in total

14 in total

Expression of VEGF(121) in gastric carcinoma MGC803 cell line.

1. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

2. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.

3. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

4. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

5. Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121).

6. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.

Review 1. Current gene therapy for stomach carcinoma.

2. Expression and bioactivity identification of soluble MG7 scFv.

3. Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma.

4. Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells.

5. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.

6. Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms.

7. Field population-based blocking treatment of esophageal epithelia dysplasia.

8. Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell.

9. Role of VEGF and CD44v6 in differentiating benign from malignant ascites.

10. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.